Biofrontera AG Sponsored ADR Consolidated Net Income/Loss

Consolidated Net Income/Loss of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Consolidated Net Income/Loss growth rates and interactive chart.


Highlights and Quick Summary

  • Consolidated Net Income/Loss for the quarter ending June 30, 2022 was $-9.01 Million (a -71.44% decrease compared to previous quarter)
  • Year-over-year quarterly Consolidated Net Income/Loss increased by 31.67%
  • Annual Consolidated Net Income/Loss for 2021 was $40.1 Million (a -4.17% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2021 was $41.8 Million (a -380.98% decrease from previous year)
  • Annual Consolidated Net Income/Loss for 2020 was $-14.9 Million (a 1.66% increase from previous year)
  • Twelve month Consolidated Net Income/Loss ending June 30, 2022 was $7.77 Million (a -35.36% decrease compared to previous quarter)
  • Twelve month trailing Consolidated Net Income/Loss decreased by -141.53% year-over-year
Trailing Consolidated Net Income/Loss for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$7.77 Million $12 Million $37.7 Million $-18.7 Million
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Consolidated Net Income/Loss of Biofrontera AG Sponsored ADR

Most recent Consolidated Net Income/Lossof BFAGY including historical data for past 10 years.

Interactive Chart of Consolidated Net Income/Loss of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Consolidated Net Income/Loss for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-9.01 $-31.53
2021 $55.15 $-6.84 $-4.76 $-5.88 $40.06
2020 $-1.23 $-7.55 $-0.08 $-6.07 $-14.88
2019 $-5.4 $-12.84 $-3.0 $-8.24
2018 $-5.31 $-10.48
2017 $-6.91 $-3.74 $-18.2
2016 $-3.85 $-11.71

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic